53
Participants
Start Date
September 27, 2017
Primary Completion Date
March 30, 2018
Study Completion Date
April 27, 2018
Placebo
0 mg
PF-06835919 Low Dose
75 mg once daily
PF-06835919 High Dose
300 mg once daily
National Clinical Research, Inc, Richmond
Avail Clinical Research, LLC, DeLand
Avail Clinical Research, LLC, Orange City
Qps-Mra, Llc, South Miami
Stand-Up MRI of Miami, Miami
WR-ClinSearch LLC, Chattanooga
Sterling Research Group, Ltd., Cincinnati
Clinical Trials of Texas, Inc., San Antonio
National Research Institute, Los Angeles
Lead Sponsor
Pfizer
INDUSTRY